Longer-Duration Dual Antiplatelet Therapy in Medically-Treated Patients after Myocardial Infarction: What is the Strength of the Evidence?

Am J Cardiol. 2024 Jun 15:221:126-127. doi: 10.1016/j.amjcard.2024.04.015. Epub 2024 Apr 20.
No abstract available

Publication types

  • Letter
  • Editorial
  • Comment

MeSH terms

  • Drug Therapy, Combination
  • Dual Anti-Platelet Therapy* / methods
  • Humans
  • Myocardial Infarction* / drug therapy
  • Platelet Aggregation Inhibitors* / administration & dosage
  • Platelet Aggregation Inhibitors* / therapeutic use
  • Time Factors

Substances

  • Platelet Aggregation Inhibitors